SC 13G/A

AMENDMENT NO. 4 TO THE SCHEDULE 13G

Company: Eledon Pharmaceuticals, Inc.
Filed: February 16, 2021
Accession Number: 0000921895-21-000474

View Document ↗ View on SEC.gov ↗